Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert E Ratner

Showing results (1-10 of 87) with videos related to

Pageof 9
Sort By:
Diabetes Technology & Therapeutics|June 7, 2018
Hypoglycemia: New Definitions and Regulatory ImplicationsRobert E Ratner
Diabetes Care|November 23, 2012
The imperative to prevent diabetesRobert E Ratner
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
An update on the Diabetes Prevention ProgramRobert E Ratner,
Diabetes Care|February 27, 2008
Prevention of type 2 diabetes in women with previous gestational diabetesRobert E Ratner
Diabetes Care|March 31, 2011
Diabetes management in the age of national health reformRobert E Ratner
The Medical Clinics of North America|February 2, 2011
Treatment recommendations for prediabetesRobert E Ratner, Anpalakan Sathasivam
The American Journal of Medicine|December 18, 2003
The roles of insulin resistance, hyperinsulinemia, and thiazolidinediones in cardiovascular diseaseGabriel I Uwaifo, Robert E Ratner
Diabetes Care|May 22, 2019
SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme CautionJoseph I Wolfsdorf, Robert E Ratner
Annals of Internal Medicine|April 7, 2017
Should We Screen for Type 2 Diabetes?Matthew P Petersen, Robert E Ratner
Expert Review of Endocrinology & Metabolism|February 16, 2019
Sitagliptin: an oral agent for glucose controlJoan K Bardsley, Robert E Ratner
Pageof 9

Showing results (1-10 of 87) with videos related to

Sort By:
Pageof 9
Diabetes Technology & Therapeutics|June 7, 2018
Hypoglycemia: New Definitions and Regulatory ImplicationsRobert E Ratner
Diabetes Care|November 23, 2012
The imperative to prevent diabetesRobert E Ratner
Endocrine Practice : Official Journal of the American College of Endocrinology and the American Association of Clinical Endocrinologists|April 22, 2006
An update on the Diabetes Prevention ProgramRobert E Ratner,
Diabetes Care|February 27, 2008
Prevention of type 2 diabetes in women with previous gestational diabetesRobert E Ratner
Diabetes Care|March 31, 2011
Diabetes management in the age of national health reformRobert E Ratner
The Medical Clinics of North America|February 2, 2011
Treatment recommendations for prediabetesRobert E Ratner, Anpalakan Sathasivam
The American Journal of Medicine|December 18, 2003
The roles of insulin resistance, hyperinsulinemia, and thiazolidinediones in cardiovascular diseaseGabriel I Uwaifo, Robert E Ratner
Diabetes Care|May 22, 2019
SGLT Inhibitors for Type 1 Diabetes: Proceed With Extreme CautionJoseph I Wolfsdorf, Robert E Ratner
Annals of Internal Medicine|April 7, 2017
Should We Screen for Type 2 Diabetes?Matthew P Petersen, Robert E Ratner
Expert Review of Endocrinology & Metabolism|February 16, 2019
Sitagliptin: an oral agent for glucose controlJoan K Bardsley, Robert E Ratner
Pageof 9